Sanofi-AstraZeneca’s preventive RSV medication is supported by a US FDA panel.
The U.S. Food and Drug Administration advisers on Thursday backed the use…
Sanofi plans to cut insulin prices in the United States in 2024, following similar cuts by Eli Lilly and Novo Nordisk.
Sanofi on Thursday said it’s planning to cut the U.S. price of its…
Sanofi announces an insulin price cap in response to steps taken by Novo Nordisk and Eli Lilly.
Sanofi, along with Eli Lilly and Novo Nordisk, make up about 90%…